{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-000677","form_type":"8-K","ticker":null,"cik":"0001761696","company_name":"Crown Electrokinetics Corp.","filed_at":"2023-01-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.449804+00:00","generated_at":"2026-06-20T20:24:43.570004+00:00","sec_items":["1.01","2.01","2.03","3.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Crown Electrokinetics acquires Amerigen 7, gains $67M Charter PO, eyes $30M revenue in 2023","bullets":["Acquired Amerigen 7 (renamed Crown Fiber Optics) for $645K cash plus assumed liabilities.","Includes a $67M purchase order from Charter Communications for fiber-optic build in Ohio.","Guides Crown Fiber Optics to generate ~$30M revenue and ~$10M EBITDA in 2023.","Raised $1.2M via senior secured notes (20% OID, zero interest, 3-month maturity) and 2.5M warrants at $0.322/share.","Warrants exercisable for 5 years at $0.322; company grants registration rights."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-000677","json":"https://secwatch.observer/filing/0001213900-23-000677.json","markdown":"https://secwatch.observer/filing/0001213900-23-000677.md","text":"https://secwatch.observer/filing/0001213900-23-000677.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1761696/000121390023000677/0001213900-23-000677-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1761696/000121390023000677/ea171181-8k_crownelectro.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T20:24:43.570004+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c1627ab5d876d9467d0536c895485538261352bf","claim":"Crown Electrokinetics Corp. incurred senior notes of $1.2 million with certain accredited investors at do not bear interest maturing three months from the date of issuance.","evidence_excerpt":"the Company sold, and the Investors purchased, $1.2 million in principal amount of senior secured notes","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761696/000121390023000677/0001213900-23-000677-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"senior notes"},{"label":"Principal","value":"$1.2 million"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Rate","value":"do not bear interest"},{"label":"Maturity","value":"three months from the date of issuance"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"ee30eecabdc885366c2273aa9355994e98abe95d","claim":"Crown Electrokinetics Corp. completed an acquisition involving Amerigen 7 LLC for $645,000 and the assumption of certain liabilities (closed 2023-01-03).","evidence_excerpt":"Amerigen sold, and the Company acquired, all of the assets of Amerigen (other than certain excluded assets set forth in the Asset Purchase Agreement) for a purchase price of (i) $645,000 and (ii) the assumption of certain liabilities of Amerigen (as set forth in the Asset Purchase Agreement). The Asset Purchase Agreement contains customary representations and","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761696/000121390023000677/0001213900-23-000677-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Amerigen 7 LLC"},{"label":"Consideration","value":"$645,000 and the assumption of certain liabilities"},{"label":"Closing","value":"2023-01-03"}],"fact_type":"ma_transaction"},{"claim_id":"7ee663c49cfc46a196a091b066919a7e8c602e48","claim":"Crown Electrokinetics Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $1.2 million (effective 2023-01-03).","evidence_excerpt":"On January 3, 2023, the Company entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain accredited investors as purchasers (the “Investors”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761696/000121390023000677/0001213900-23-000677-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"$1.2 million"},{"label":"Effective","value":"2023-01-03"}],"fact_type":"material_agreement"},{"claim_id":"b71c70d501a5bbabd2c51946d06bf3b47906e0d1","claim":"Crown Electrokinetics Corp. entered into Asset Purchase Agreement with Amerigen 7 LLC valued at $645,000 (effective 2023-01-03).","evidence_excerpt":"The Asset Acquisition was simultaneously entered into and consummated pursuant to a certain Asset Purchase Agreement (the “Asset Purchase Agreement”) with Amerigen 7 LLC, a Texas limited liability company (“Amerigen”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761696/000121390023000677/0001213900-23-000677-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Amerigen 7 LLC"},{"label":"Value","value":"$645,000"},{"label":"Effective","value":"2023-01-03"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}